BioLife Solutions Stock Forward View - Simple Exponential Smoothing
| BLFS Stock | USD 19.82 -0.04 -0.20% |
Momentum 37
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth -0.14 | EPS Estimate Next Quarter 0.02 | EPS Estimate Current Year 0.135 | EPS Estimate Next Year 0.29 | Wall Street Target Price 32.4 |
Hype-based context for BioLife Solutions connects recent headlines with price response and peer activity. This sentiment summary combines BioLife Solutions' options data with short interest context.
Short Interest Snapshot - BioLife Solutions
Short interest in BioLife Solutions is a useful contrarian indicator. Extreme levels of short interest can precede sharp short-covering rallies if positive news surprises the market.
200 Day MA 24.1791 | Short Percent 0.0943 | Short Ratio 9.1 | Shares Short Prior Month 2.9 M | 50 Day MA 23.4638 |
RSI Overview - BioLife
The Simple Exponential Smoothing forecasted value of BioLife Solutions on the next trading day is expected to be 19.82 with a mean absolute deviation of 0.48 and the sum of the absolute errors of 28.91.Hype and Price Pattern for BioLife Solutions
BioLife Solutions' news sentiment aggregates headline tone and social media engagement to build a real-time gauge of investor psychology around BioLife. Sentiment extremes often precede price reversals.
The correlation between BioLife Solutions' news sentiment and price provides a measurable basis for market timing. A strong positive correlation suggests sentiment is currently driving price; a negative one may indicate a potential reversal.
BioLife Solutions Implied Volatility | 1.51 |
Unlike historical volatility, which measures past price movements, BioLife Solutions' implied volatility is a real-time gauge of how much uncertainty the options market is pricing into BioLife Solutions's future price action.
The Simple Exponential Smoothing forecasted value of BioLife Solutions on the next trading day is expected to be 19.82 with a mean absolute deviation of 0.48 and the sum of the absolute errors of 28.91.BioLife Solutions after-hype prediction price | USD 19.9 |
This sentiment layer is designed to be read with forecasting, technical, analyst, earnings, and momentum context.
Use Historical Fundamental Analysis of BioLife Solutions to cross-verify projections for BioLife Solutions. The historical series provides projection context.Rule 16 for the current BioLife contract - Risk Context
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 0.0944% for the 2026-04-17 options. The figure is a neutral volatility reference; near USD 19.82, it implies about USD 0.0187 per day.
Open Interest vs. 2026-04-17 BioLife Options
The open interest view shows outstanding BioLife Solutions option contracts, providing context on participation and contract flow.
BioLife Solutions Additional Predictive Modules
Most predictive techniques to examine BioLife price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioLife using various technical indicators. When you analyze BioLife charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BioLife Solutions Simple Exponential Smoothing Price Forecast For the 10th of March
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of BioLife Solutions on the next trading day is expected to be 19.82 with a mean absolute deviation of 0.48 , mean absolute percentage error of 0.48 , and the sum of the absolute errors of 28.91 .Please note that although there have been many attempts to predict BioLife Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BioLife Solutions' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BioLife Solutions Stock Forecast Pattern
| Backtest BioLife Solutions | BioLife Solutions Price Prediction | Research Analysis |
BioLife Solutions Forecasted Value
This next-day forecast for BioLife Solutions uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of BioLife Solutions stock data series using in forecasting. Note that when a statistical model is used to represent BioLife Solutions stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.5285 |
| Bias | Arithmetic mean of the errors | 0.0822 |
| MAD | Mean absolute deviation | 0.4818 |
| MAPE | Mean absolute percentage error | 0.0207 |
| SAE | Sum of the absolute errors | 28.91 |
Mean reversion in BioLife Solutions' price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
BioLife Solutions After-Hype Price Density Analysis
Understanding BioLife Solutions' probability distribution helps investors calibrate position size to their risk tolerance. The tails of the BioLife Solutions distribution capture low-probability but high-impact outcomes that naive point estimates ignore.
Next price density |
| Expected price to next headline |
BioLife Solutions Estimiated After-Hype Price Volatility
Using BioLife Solutions' historical news impact data, we estimate the likely price corridor for the next trading session after a significant headline. BioLife Solutions' after-hype downside and upside margins for the prediction period are 17.00 and 22.80, respectively. Note that past news reactions for BioLife Solutions are not guaranteed to repeat, particularly in novel market environments.
Current Value
The after-hype framework applied to BioLife Solutions assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
BioLife Solutions Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as BioLife Solutions is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioLife Solutions backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BioLife Solutions, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.32 | 2.90 | 0.08 | 0.10 | 10 Events | 8 Events | In 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
19.82 | 19.90 | 0.40 |
|
BioLife Solutions Hype Timeline
BioLife Solutions is currently traded for 19.82. The entity has historical hype elasticity of 0.08, and average elasticity to hype of competition of 0.1. BioLife is forecasted to increase in value after the next headline, with the price projected to jump to 19.9 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 0.4%, whereas the daily expected return is currently at -0.32%. The volatility of related hype on BioLife Solutions is about 932.48%, with the expected price after the next announcement by competition of 19.92. The company reported the previous year's revenue of 96.21 M. Net Loss for the year was -20.18 M with profit before overhead, payroll, taxes, and interest of 62.12 M. Given the investment horizon of 90 days the next forecasted press release will be in 10 days. Use Historical Fundamental Analysis of BioLife Solutions to cross-verify projections for BioLife Solutions. The historical series provides projection context.BioLife Solutions Related Hype Analysis
Understanding how BioLife Solutions' direct competitors react to news events helps investors anticipate contagion effects and sector-wide sentiment shifts that may affect BioLife Solutions's performance.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KMTS | Kestra Medical Technologies | -1.45 | 10 per month | 0.00 | -0.02 | 5.06 | -5.85 | 20.54 | |
| NVCR | Novocure | 0.50 | 8 per month | 4.10 | 0.05 | 6.92 | -8.27 | 35.96 | |
| AZTA | Azenta Inc | 1.36 | 8 per month | 0.00 | -0.13 | 3.44 | -5.03 | 29.88 | |
| STAA | STAAR Surgical | 0.61 | 13 per month | 0.00 | -0.14 | 5.26 | -5.51 | 15.08 | |
| PHR | Phreesia | -0.60 | 9 per month | 0.00 | -0.19 | 2.77 | -4.84 | 24.45 | |
| PLSE | Pulse Biosciences | 1.91 | 10 per month | 3.89 | 0.09 | 7.62 | -5.94 | 66.16 | |
| NEOG | Neogen | 0.05 | 11 per month | 1.70 | 0.18 | 5.56 | -2.56 | 34.17 | |
| HROW | Harrow Health | 1.44 | 11 per month | 0.00 | -0.002 | 6.42 | -7.78 | 38.78 | |
| ATRC | AtriCure | 0.09 | 6 per month | 0.00 | -0.06 | 3.39 | -3.34 | 24.05 | |
| ESTA | Establishment Labs Holdings | -0.80 | 9 per month | 2.97 | 0.03 | 4.55 | -5.74 | 13.50 |
Other Forecasting Options for BioLife Solutions
The price movement of BioLife is a central concern for all potential investors, regardless of their level of expertise. BioLife Stock price charts can be difficult to interpret due to the noise present in the data.BioLife Solutions Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioLife Solutions stock to make a market-neutral strategy. Peer analysis of BioLife Solutions could also be used in its relative valuation, which is a method of valuing BioLife Solutions by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BioLife Solutions Market Strength Events
Market strength indicators applied to BioLife Solutions stock help investors assess the relative momentum and resilience of the security in different market environments. By using these indicators, traders can make more informed decisions about when to buy or sell BioLife Solutions.
BioLife Solutions Risk Indicators
Risk indicator analysis for BioLife Solutions' is essential for accurately projecting its future price trajectory. By identifying the level of risk embedded in BioLife Solutions' investment, investors can make informed decisions about position sizing and risk mitigation.
| Mean Deviation | 1.95 | |||
| Standard Deviation | 2.81 | |||
| Variance | 7.88 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for BioLife Solutions
Coverage intensity for BioLife Solutions matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
BioLife Solutions Short Properties
Short sentiment tied to BioLife Solutions matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 48.6 M | |
| Cash And Short Term Investments | 88.9 M |
Additional Tools for BioLife Stock Analysis
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |